DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

GlaxoSmithKline (NYSE: GSK)

44.00 -1.16 (-2.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $44.00 -2.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.61
Previous Close $45.16
Daily Range $44.00 - $44.67
52-Week Range $41.25 - $56.73
Market Cap $105.7B
P/E Ratio 15.52
Dividend (Yield) $2.45 (5.9%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 3,043,063
Average Daily Volume 4,052,613
Current FY EPS $2.98

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

Vaccine Controversy Hits Big Pharma: Who Will Pay?

How much should Big Pharma charge for vaccines used in poor countries? The controversy rages on.

Big Pharma: An Up-Close Look at One Key Player

Industry Focus zooms in on restructuring, new drugs, and possible threats for pharma giant Novartis.

Can GlaxoSmithKline Continue Striving in the Face of World Challenges?

27.79% Advantage In 5 Lowest-Priced, Highest-Yield Super Sector Dividend Dogs Of January

Tumor Drug Takes The Focus At OncoMed Pharmaceuticals

Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog

A Sad Reality: 3 of Healthcare's Top 5 Dividends Probably Aren't Sustainable

Three of healthcare's top five high-yield dividend stocks are probably going to cut their payouts sooner than later.

What Investors Should Do About Imminent Obesity Drug Approvals In Europe

Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog

GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD

See More GSK News...

GSK's Top Competitors

GSK $44.00 (-2.57%)
Current stock: GSK
JNJ $100.14 (-2.19%)
Current stock: JNJ
NVS $97.40 (-1.77%)
Current stock: NVS
RHHBY $33.78 (-1.75%)
Current stock: RHHBY